$
90.61
10:08 PM EST
New Key Statistics Module, Z-Score and F-Score
OTCPK:LABFF Key Ratios
Market Cap $ M | 4,788.13 |
Enterprise Value $ M | 4,862.90 |
P/E(ttm) | 32.81 |
PE Ratio without NRI | 32.74 |
Forward PE Ratio | -- |
Price/Book | 8.52 |
Price/Sales | 5.80 |
Price/Free Cash Flow | 99.65 |
Price/Owner Earnings | 45.44 |
Payout Ratio % | 0.49 |
Revenue (TTM) $ M | 842.00 |
EPS (TTM) $ | 2.84 |
Beneish M-Score | -2.23 |
10-y EBITDA Growth Rate % | 25.30 |
5-y EBITDA Growth Rate % | 57.50 |
y-y EBITDA Growth Rate % | -25.60 |
EV-to-EBIT | 25.03 |
EV-to-EBITDA | 21.95 |
PEG | 0.57 |
Shares Outstanding M | 51.15 |
Net Margin (%) | 17.69 |
Operating Margin % | 22.95 |
Pre-tax Margin (%) | 22.88 |
Quick Ratio | 0.77 |
Current Ratio | 2.54 |
ROA % (ttm) | 16.43 |
ROE % (ttm) | 25.58 |
ROIC % (ttm) | 22.64 |
Dividend Yield % | 1.32 |
Altman Z-Score | 13.63 |
LABFF Number of Guru Trades
LABFF Volume of Guru Trades
Gurus Latest Trades with OTCPK:LABFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:LABFF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Laboratorios Farmaceuticos Rovi SA Insider Transactions
No Available Data
News about OTCPK:LABFF
Total 0- 1